Search bioRxiv⌕ Search

Biology subjects

Pascoe, J.

Publications and source records attributed to Pascoe, J..

2 recordsLinked to original sources

A new genetic method for diet determination from faeces that provides species level resolution in the koala

An animals diet is a crucial trait that defines their realised ecological niche, especially for dietary specialists such as the koala (Phascolarctos cinereus), a threatened arboreal marsupial folivore. Unfortunately, the current methods used to characterise koala diet are labour intensive, biased and/or unreliable. Further, in this study we show that four barcoding genes (ITS, ETS, CCR and matK) are unable to resolve potential koala food trees to species. Therefore, we developed and tested a novel SNP-based method for the analysis of koala diet from faeces using the DArTseq platform. This method returned a large number of species-specific SNPs for candidate koala food tree species. Due to low within-species variation, few individuals of each tree species are needed to capture the majority of DArTseq SNP diversity. Nonetheless, we suggest sampling multiple trees to reduce the impact of high allele dropout rates in the DArTseq data. After identifying species-specific SNPs from candidate food tree species from two study sites with different assemblages of eucalypts we were able to detect those SNPs in koala faecal DNA using DArTag, a targeted genotyping assay. This enabled us to semi-quantitatively characterise the koalas diets. The food tree species identified were in broad agreement with previously known koala food tree species but also revealed additional species that may contribute to koala diet. This approach provides an important new tool for use in koala ecology and conservation and may prove useful in diet determination for other species where high taxonomic resolution is crucial and dietary DNA is scarce.

microbiology↗

Azetidines kill Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly.

Tuberculosis (TB) is the leading cause of global morbidity and mortality resulting from infectious disease, with over 10 million new cases and 1.5 million deaths in 2019. This global emergency is exacerbated by the emergence of multi-drug-resistant MDR-TB and extensively-drug-resistant XDR-TB, therefore new drugs and new drug targets are urgently required. From a whole-cell phenotypic screen a series of azetidines derivatives termed BGAz, that elicit potent bactericidal activity with MIC99 values <10 M against drug-sensitive Mycobacterium tuberculosis and MDR-TB were identified. These compounds demonstrate no detectable drug resistance. Mode of action and target deconvolution studies suggest that these compounds inhibit mycobacterial growth by interfering with cell envelope biogenesis, specifically late-stage mycolic acid biosynthesis. Transcriptomic analysis demonstrates that the BGAz compounds tested display a mode of action distinct from existing mycobacterial cell-wall inhibitors. In addition, the compounds tested exhibit toxicological and PK/PD profiles that pave the way for their development as anti-tubercular chemotherapies.

microbiology↗